ITP53/I and/or IBRCA1/I Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast Cancer

For effective cancer treatment, it is important to scrutinize individual driver gene mutations. In this study, we investigated whether analyzing gene mutations in primary breast cancer based on ctDNA could be a biomarker of prognosis using plasma from 95 patients with primary breast cancer. The key...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancers 2024-03, Vol.16 (6)
Hauptverfasser:	Arimura, Akiko, Sakai, Kazuko, Kaneshiro, Kazuhisa, Morisaki, Takafumi, Hayashi, Saori, Mizoguchi, Kimihisa, Yamada, Mai, Kai, Masaya, Ono, Mayumi, Nishio, Kazuto, Nakamura, Masafumi, Kubo, Makoto
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Biological markers Breast cancer Cancer Cancer patients Care and treatment Ethylenediaminetetraacetic acid Gene mutations Genes Genetic aspects Genomics Health aspects Oncology, Experimental Prognosis Tumor proteins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!